Bomholt Signe F, Mikkelsen Jens D, Blackburn-Munro Gordon
Department of Pharmacology, NeuroSearch A/S, 93 Pederstrupvej, DK-2750, Ballerup, Denmark.
Brain Res. 2005 May 24;1044(2):216-26. doi: 10.1016/j.brainres.2005.03.005. Epub 2005 Apr 13.
Chronic pain conditions such as rheumatoid arthritis and fibromyalgia are associated with profound hypothalamo-pituitary-adrenal (HPA) axis dysfunction which may exacerbate symptoms of chronic pain. HPA axis dysfunction has also been well documented in animal models of chronic inflammatory pain. However, the role of the HPA axis in animal models of neuropathic pain is currently unknown. Rats with a chronic constriction injury (CCI) of the sciatic nerve that developed marked mechanical allodynia and hyperalgesia of the injured hindpaw were used to determine basal and stimulatory levels of HPA axis activity. Plasma ACTH and corticosterone levels were increased significantly (P < 0.05) in CCI rats after 20 min restraint stress compared with baseline; however, the magnitude of the increase was no different from sham rats. Furthermore, the temporal profile of ACTH release over the 60 min period after termination of restraint was similar between CCI and sham rats suggesting normal glucocorticoid-mediated feedback. Restraint stress also significantly increased (P < 0.05) expression of the immediate early genes c-Fos and FosB within the hypothalamic PVN to a similar extent in CCI and sham rats. Within the parvocellular PVN basal expression of both CRF and AVP mRNA was no different between CCI and sham rats; restraint stress induced a significant 2.5 fold increase (P < 0.05) in CRF mRNA expression in sham rats only. These results suggest that, in contrast to inflammatory immune-mediated pain models where HPA axis function is profoundly altered, in the CCI model of neuropathic pain, basal HPA axis function is unchanged. Furthermore, the HPA axis responds normally to a novel stressor in the face of ongoing nociceptive input, a stimulus known to activate the HPA axis.
类风湿性关节炎和纤维肌痛等慢性疼痛病症与下丘脑 - 垂体 - 肾上腺(HPA)轴功能严重失调有关,这可能会加重慢性疼痛的症状。HPA轴功能失调在慢性炎症性疼痛的动物模型中也有充分的记录。然而,HPA轴在神经性疼痛动物模型中的作用目前尚不清楚。将坐骨神经发生慢性缩窄损伤(CCI)且受伤后爪出现明显机械性异常性疼痛和痛觉过敏的大鼠用于确定HPA轴活动的基础水平和刺激水平。与基线相比,在约束应激20分钟后,CCI大鼠的血浆促肾上腺皮质激素(ACTH)和皮质酮水平显著升高(P < 0.05);然而,升高幅度与假手术大鼠没有差异。此外,在约束终止后的60分钟内,CCI大鼠和假手术大鼠ACTH释放的时间曲线相似,表明糖皮质激素介导的反馈正常。约束应激还使下丘脑室旁核(PVN)内即刻早期基因c-Fos和FosB的表达在CCI大鼠和假手术大鼠中同样显著增加(P < 0.05)。在小细胞PVN内,促肾上腺皮质激素释放因子(CRF)和精氨酸加压素(AVP)mRNA的基础表达在CCI大鼠和假手术大鼠之间没有差异;约束应激仅使假手术大鼠的CRF mRNA表达显著增加2.5倍(P < 0.05)。这些结果表明,与HPA轴功能发生深刻改变的炎症免疫介导性疼痛模型不同,在神经性疼痛的CCI模型中,基础HPA轴功能未发生改变。此外,面对持续的伤害性输入(一种已知可激活HPA轴的刺激),HPA轴对新的应激源反应正常。